» Articles » PMID: 23329645

Twist1 Induces CCL2 and Recruits Macrophages to Promote Angiogenesis

Overview
Journal Cancer Res
Specialty Oncology
Date 2013 Jan 19
PMID 23329645
Citations 109
Authors
Affiliations
Soon will be listed here.
Abstract

The transcription factor Twist1 induces epithelial-mesenchymal transition and extracellular matrix degradation to promote tumor metastasis. Although Twist1 also plays a role in embryonic vascular development and tumor angiogenesis, the molecular mechanisms that underlie these processes are not as well understood. Here, we report a novel function for Twist1 in modifying the tumor microenvironment to promote progression. We found that expression of Twist1 in human mammary epithelial cells potently promoted angiogenesis. Surprisingly, Twist1 expression did not increase the secretion of the common proangiogenic factors VEGF and basic fibroblast growth factor but rather induced expression of the macrophage chemoattractant CCL2. Attenuation of endogenous Twist1 in vivo blocked macrophage recruitment and angiogenesis, whereas exogenous CCL2 rescued the ability of tumor cells lacking Twist1 to attract macrophages and promote angiogenesis. Macrophage recruitment also was essential for the ability of Twist1-expressing cells to elicit a strong angiogenic response. Together, our findings show that how Twist1 recruits stromal macrophages through CCL2 induction to promote angiogenesis and tumor progression. As Twist1 expression has been associated with poor survival in many human cancers, this finding suggests that anti-CCL2 therapy may offer a rational strategy to treat Twist1-positive metastatic cancers.

Citing Articles

The role of tumor-associated macrophages in lung cancer.

Zhu R, Huang J, Qian F Front Immunol. 2025; 16:1556209.

PMID: 40079009 PMC: 11897577. DOI: 10.3389/fimmu.2025.1556209.


Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition.

Glaviano A, Lau H, Carter L, Lee E, Lam H, Okina E J Hematol Oncol. 2025; 18(1):6.

PMID: 39806516 PMC: 11733683. DOI: 10.1186/s13045-024-01634-6.


Cardamonin anticancer effects through the modulation of the tumor immune microenvironment in triple-negative breast cancer cells.

Mendonca P, Kaur S, Kirpal B, Soliman K Am J Cancer Res. 2025; 14(12):5644-5664.

PMID: 39803666 PMC: 11711538. DOI: 10.62347/ANXS3815.


The transcription factor FOXQ1 in cancer.

Koch S Cancer Metastasis Rev. 2025; 44(1):22.

PMID: 39777582 PMC: 11711781. DOI: 10.1007/s10555-025-10240-y.


Targeting cytokine and chemokine signaling pathways for cancer therapy.

Yi M, Li T, Niu M, Zhang H, Wu Y, Wu K Signal Transduct Target Ther. 2024; 9(1):176.

PMID: 39034318 PMC: 11275440. DOI: 10.1038/s41392-024-01868-3.


References
1.
Mani S, Guo W, Liao M, Eaton E, Ayyanan A, Zhou A . The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008; 133(4):704-15. PMC: 2728032. DOI: 10.1016/j.cell.2008.03.027. View

2.
Collino F, Revelli A, Massobrio M, Katsaros D, Schmitt-Ney M, Camussi G . Epithelial-mesenchymal transition of ovarian tumor cells induces an angiogenic monocyte cell population. Exp Cell Res. 2009; 315(17):2982-94. DOI: 10.1016/j.yexcr.2009.06.010. View

3.
Qian B, Deng Y, Im J, Muschel R, Zou Y, Li J . A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth. PLoS One. 2009; 4(8):e6562. PMC: 2721818. DOI: 10.1371/journal.pone.0006562. View

4.
Lu X, Kang Y . Chemokine (C-C motif) ligand 2 engages CCR2+ stromal cells of monocytic origin to promote breast cancer metastasis to lung and bone. J Biol Chem. 2009; 284(42):29087-96. PMC: 2781454. DOI: 10.1074/jbc.M109.035899. View

5.
Lin E, Li J, Gnatovskiy L, Deng Y, Zhu L, Grzesik D . Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res. 2006; 66(23):11238-46. DOI: 10.1158/0008-5472.CAN-06-1278. View